Revvity Inc
RVTY94.685USD
-0.375-0.39%
收盘 04/29, 16:00（美东）报价延迟15分钟
11.42B总市值
42.25市盈率 TTM
关于 Revvity Inc 公司
Revvity, Inc. 是一家健康科学解决方案、技术和服务提供商，提供从发现到开发、从诊断到治疗的工作流程。其部门包括生命科学和诊断。生命科学部门提供面向生命科学市场的产品和服务。生命科学部门的应用包括 MicroBeta、MuviCyte 活细胞成像系统、Signals Image Artist、VICTOR Nivo 多模式平板读取器台式系统、EnSight 多模式平板读取器台式系统、BioLegend LEGENDplex 基于珠子的试剂和 Quantum GX2 系统。其诊断部门开发诊断、工具和应用程序，专注于生殖健康、免疫诊断和应用基因组学市场的临床导向客户。它为医院和医疗实验室提供仪器、试剂、检测平台和软件。它专注于生殖健康、免疫诊断和新兴市场诊断。
公司简介
公司代码RVTY
公司名称Revvity Inc
上市日期Jul 06, 1965
成立日期1947
CEODr. Prahlad R. Singh, Ph.D.
员工数量11000
证券类型Ordinary Share
年结日Jul 06
公司地址77 4Th Avenue
城市WALTHAM
上市交易所NYSE Consolidated
国家United States of America
邮编02451
电话17816636900
网址https://www.revvity.com/
公司代码RVTY
上市日期Jul 06, 1965
成立日期1947
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
106.26K
+17.81%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
42.60K
-0.26%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
37.69K
+12.84%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
23.60K
+3.43%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
23.36K
+628.47%
Mr. Tajinder S. Vohra
Mr. Tajinder S. Vohra
Senior Vice President - Global Operations
Senior Vice President - Global Operations
22.63K
+137.66%
Ms. Miriame Victor
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
14.29K
+61.74%
Ms. Pascale Witz
Ms. Pascale Witz
Independent Director
Independent Director
11.29K
+7.45%
Mrs. Anita Gonzales
Mrs. Anita Gonzales
Vice President, Controller
Vice President, Controller
4.52K
+19.31%
Ms. Michelle Mcmurry-Heath, M.D., Ph.D.
Ms. Michelle Mcmurry-Heath, M.D., Ph.D.
Independent Director
Independent Director
3.02K
-28.21%
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
106.26K
+17.81%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
42.60K
-0.26%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
37.69K
+12.84%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
23.60K
+3.43%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
23.36K
+628.47%
Mr. Tajinder S. Vohra
Mr. Tajinder S. Vohra
Senior Vice President - Global Operations
Senior Vice President - Global Operations
22.63K
+137.66%
收入明细
单位: USD更新时间: 4月6日 周日
单位: USD更新时间: 4月6日 周日
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
暂无数据
地区USD
名称
营收
占比
Americas
1.22B
44.39%
United States
1.10B
39.85%
Other Foreign
1.09B
39.72%
Asia
789.33M
28.65%
Europe
742.61M
26.95%
Other
-2.19B
-79.57%
业务
地区
暂无数据
股东统计
更新时间: 2月21日 周五
更新时间: 2月21日 周五
持股股东
股东类型
持股股东
股东统计
占比
T. Rowe Price Investment Management, Inc.
17.28%
The Vanguard Group, Inc.
11.85%
T. Rowe Price Associates, Inc.
6.21%
Janus Henderson Investors
5.29%
BlackRock Institutional Trust Company, N.A.
5.00%
Other
54.37%
持股股东
股东统计
占比
T. Rowe Price Investment Management, Inc.
17.28%
The Vanguard Group, Inc.
11.85%
T. Rowe Price Associates, Inc.
6.21%
Janus Henderson Investors
5.29%
BlackRock Institutional Trust Company, N.A.
5.00%
Other
54.37%
股东类型
股东统计
占比
Investment Advisor
52.38%
Investment Advisor/Hedge Fund
34.65%
Hedge Fund
2.53%
Bank and Trust
1.60%
Pension Fund
1.55%
Research Firm
1.34%
Sovereign Wealth Fund
1.02%
Individual Investor
0.29%
Family Office
0.05%
Other
4.58%
机构持股
更新时间: 1月20日 周一
更新时间: 1月20日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q1
1212
114.89M
95.62%
-2.87M
2024Q4
1277
114.54M
95.28%
-3.97M
2024Q3
1253
112.35M
91.11%
-5.77M
2024Q2
1249
112.44M
91.13%
-1.63M
2024Q1
1287
107.57M
87.09%
-8.24M
2023Q4
1315
109.29M
88.55%
-2.41M
2023Q3
1347
106.10M
85.47%
-6.10M
2023Q2
1383
106.88M
85.21%
-9.65M
2023Q1
1406
108.31M
85.69%
-5.19M
2022Q4
1441
108.60M
86.00%
-7.85M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
T. Rowe Price Investment Management, Inc.
20.76M
17.28%
+2.97M
+16.69%
Dec 31, 2024
The Vanguard Group, Inc.
14.24M
11.85%
+157.96K
+1.12%
Dec 31, 2024
T. Rowe Price Associates, Inc.
7.46M
6.21%
+1.15M
+18.27%
Dec 31, 2024
Janus Henderson Investors
6.36M
5.29%
+23.65K
+0.37%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
6.01M
5%
-158.82K
-2.58%
Dec 31, 2024
State Street Global Advisors (US)
5.17M
4.3%
-13.79K
-0.27%
Dec 31, 2024
EdgePoint Investment Group Inc.
4.06M
3.38%
+1.37M
+51.10%
Dec 31, 2024
Mitsubishi UFJ Asset Management Co., Ltd.
3.38M
2.82%
+69.03K
+2.08%
Dec 31, 2024
Capital Research Global Investors
2.99M
2.49%
-97.75K
-3.17%
Dec 31, 2024
Geode Capital Management, L.L.C.
2.90M
2.41%
+37.67K
+1.32%
Dec 31, 2024
查看更多
持股ETF
更新时间: 4月6日 周日
更新时间: 4月6日 周日
机构名称
占比
Otter Creek Focus Strategy ETF
2.72%
T Rowe Price Capital Appreciation Equity ETF
2.21%
Franklin Genomic Advancements ETF
1.87%
Invesco S&P 500 Equal Weight Health Care ETF
1.52%
Simplify Health Care ETF
1.28%
VanEck Morningstar SMID Moat ETF
1.25%
First Trust Indxx Medical Devices ETF
1.24%
Janus Henderson US Sustainable Equity ETF
1.11%
First Trust Health Care Alphadex Fund
0.87%
ROBO Global Healthcare Technology & Innovation ETF
0.86%
查看更多
Otter Creek Focus Strategy ETF
占比2.72%
T Rowe Price Capital Appreciation Equity ETF
占比2.21%
Franklin Genomic Advancements ETF
占比1.87%
Invesco S&P 500 Equal Weight Health Care ETF
占比1.52%
Simplify Health Care ETF
占比1.28%
VanEck Morningstar SMID Moat ETF
占比1.25%
First Trust Indxx Medical Devices ETF
占比1.24%
Janus Henderson US Sustainable Equity ETF
占比1.11%
First Trust Health Care Alphadex Fund
占比0.87%
ROBO Global Healthcare Technology & Innovation ETF
占比0.86%
分红派息
近5年累计派现
168.35M
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Oct 24, 2024
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 07, 2025 going ex on Jan 17, 2025
Jan 17, 2025
Feb 07, 2025
Jan 17, 2025
Jul 25, 2024
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 08, 2024 going ex on Oct 18, 2024
Oct 18, 2024
Nov 08, 2024
Oct 18, 2024
Apr 25, 2024
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 09, 2024 going ex on Jul 19, 2024
Jul 19, 2024
Aug 09, 2024
Jul 19, 2024
Jan 25, 2024
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 10, 2024 going ex on Apr 18, 2024
Apr 19, 2024
May 10, 2024
Apr 18, 2024
Oct 26, 2023
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Feb 09, 2024 going ex on Jan 18, 2024
Jan 19, 2024
Feb 09, 2024
Jan 18, 2024
Jul 21, 2023
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 10, 2023 going ex on Oct 19, 2023
Oct 20, 2023
Nov 10, 2023
Oct 19, 2023
Apr 25, 2023
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 11, 2023 going ex on Jul 20, 2023
Jul 21, 2023
Aug 11, 2023
Jul 20, 2023
Jan 26, 2023
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 12, 2023 going ex on Apr 20, 2023
Apr 21, 2023
May 12, 2023
Apr 20, 2023
Oct 27, 2022
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Feb 10, 2023 going ex on Jan 19, 2023
Jan 20, 2023
Feb 10, 2023
Jan 19, 2023
Jul 22, 2022
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 11, 2022 going ex on Oct 20, 2022
Oct 21, 2022
Nov 11, 2022
Oct 20, 2022
查看更多
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据